A busy Tuesday premarket sees profit warnings and strategic pivots sit alongside operational milestones and guidance upgrades, with Associated British Foods (LSE:ABF) setting the tone at the top after a sharp earnings decline and a landmark structural announcement. Housebuilder Crest Nicholson (LSE:CRST) adds to the pressure on the consumer and construction complex, while several smaller names deliver beats that cut against the cautious macro grain.
Associated British Foods
Associated British Foods (LSE:ABF) reports an 18% fall in adjusted operating profit for the 24 weeks to 28 February, with group revenue also slipping 2%. The headline numbers reflect pressure across the diversified food-to-fashion conglomerate, though management held the interim dividend and flagged increased investment across the portfolio. The most significant strategic development is the confirmation of a planned demerger of Primark, a move that would separate the fast-fashion retailer from the broader food ingredients and grocery businesses and crystallise value that has long been debated by shareholders.
The demerger announcement reframes the profit decline as a transitional moment rather than a structural deterioration. Associated British Foods enters the separation process with its balance sheet intact and a dividend maintained, giving management a degree of credibility as it navigates what will be a complex corporate restructuring.
Griffin Mining
Griffin Mining (LSE:GFM) marks a material operational milestone, completing its first production blast in Zone II on 20 April following the conclusion of 19.4km of statutory mine development and 625 metres of ventilation shaft construction. The company says ore will now be mined continuously under its current licence, which runs to 2054, providing a long-dated production runway that underpins the investment case for the Chinese zinc and gold operation.
British Land
British Land (LSE:BLND) upgrades its earnings outlook after a strong leasing cycle and a strategic acquisition. The REIT now expects FY26 Underlying EPS of 28.9p and has raised FY27 Underlying EPS guidance to at least 30.5p, supported by like-for-like net rental growth of 6% across its campus and retail park portfolio. The acquisition of Life Science REIT adds a growth vector in a structurally supported asset class and broadens the income base heading into the next financial year.
Gear4music
Gear4music (AIM:G4M) closes its financial year ahead of market expectations, reporting EBITDA of not less than £18.1m and profit before tax of not less than £9.7m for the 12 months to 31 March 2026. The online musical instruments retailer says FY27 trading to date is running in line with market expectations, providing continuity of confidence into the new year. The beat against consensus positions Gear4music as one of the cleaner consumer-facing stories in today's premarket.
Crest Nicholson
Crest Nicholson (LSE:CRST) narrows its full-year volume guidance to 1,400–1,500 homes and now expects EBIT of approximately £5m–£15m, a range that signals significant earnings uncertainty. Land-sale revenue is seen at around £40m as the housebuilder prioritises cash preservation over growth. Management is also seeking temporary covenant relief, a disclosure that will focus attention on the balance sheet and the pace of any recovery in the UK new-build market.
Intercede Group
Intercede Group (AIM:IGP), trading at 88.3p (-0.23%), secures approximately $3.8m of orders from US and UK government customers, the bulk of which represents an upsell to a large US Federal Agency for MyID CMS perpetual licences, support and maintenance. Orders were booked via channel partners, consistent with the company's indirect sales model. The contract reinforces Intercede's position in identity and credential management for high-security government environments on both sides of the Atlantic.
CRISM Therapeutics Corporation
CRISM Therapeutics Corporation (CSE:CRISM) publishes preclinical data showing its Docetaxel-ChemoSeed device cut tumour volume by up to 58% compared with systemic docetaxel in a prostate cancer model. The results demonstrate a clear dose-response relationship and fewer tolerability issues than the systemic comparator, supporting the rationale for localised chemotherapy delivery. While preclinical data carries inherent limitations before human trials, the magnitude of the tumour reduction and the tolerability profile are the key numbers investors will focus on.
Accsys Technologies
Accsys Technologies (LSE:AXS) reports record annual Accoya wood sales of 77,237 cubic metres, representing like-for-like revenue growth of 20%, and says FY26 adjusted EBITDA will be in line with market consensus. The record volume figure is the headline achievement, demonstrating that demand for the acetylated wood product continues to expand despite a mixed European construction backdrop. Consensus-matching EBITDA guidance provides a clean exit to the financial year without a downgrade.
Facilities by ADF
Facilities by ADF (AIM:ADF) grows full-year revenue by 17% to £41.3m for the year ended 31 December 2025, with adjusted EBITDA rising 28% to £9.2m. The stronger EBITDA growth relative to revenue reflects improved asset utilisation and the full-year contribution from the Autotrak acquisition. Net debt fell to £12.3m and no final dividend is proposed, suggesting capital is being retained to support continued investment in the film and television production services fleet.
IXICO
IXICO (AIM:IXI) flags first-half revenue growth of 23% to £3.9m, with gross margin improving to 53% and the EBITDA loss narrowing to £0.5m. The signed order book expands to £18.1m, providing forward revenue visibility for the neuroimaging data and analytics business. Interim results are scheduled for 19 May.
Market Pulse
Two distinct narratives run through today's premarket. The first is strategic repositioning under earnings pressure — Associated British Foods accelerates a structural break-up as profits fall, while Crest Nicholson seeks covenant relief and tightens guidance, both reflecting companies managing through a difficult operating environment rather than growing through it. The second is operational delivery: Griffin Mining's Zone II blast, Accsys's record volumes, Gear4music's consensus beat and British Land's guidance upgrade all represent companies executing on plans and rewarding patience. The divergence between these two groups is as sharp as any seen in a single premarket session this year.
Government-facing technology also asserts itself quietly. Intercede's $3.8m order reinforces the durability of identity security spending in the public sector, a theme that has proved resilient across multiple macro cycles. CRISM's preclinical data sits in a different category — early-stage science that moves the story forward without yet constituting a clinical proof point — but the 58% tumour reduction figure is large enough to sustain investor attention through the next trial phase.
